Collectively, the present findings identify the hsa_circ_0002872/hsa-miR-29b-1–5p/ZBTB46 axis as a novel regulator of lung cancer progression, with ZBTB46 serving as a potential prognostic marker and therapeutic target. This evidence concerns the gene ZBTB46 and lung carcinoma.